Sparks set to fly at Australian hearing on access to cancer drugs
This article was originally published in Scrip
Executive Summary
A public hearing is to be held in Canberra on 20 April as part of a review of patient access to new, innovative and specialist cancer drugs in Australia that is being conducted by the Senate's Community Affairs References Committee.